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1 The normalization of abnormally high numbers of circulating myeloid  
cell levels, induced by cytotoxic treatment with carboplatin and paclitaxel, 
is one of the mechanisms of action of these chemotherapeutic compounds. 
(this thesis)
2 A potential strategy to achieve successful combination therapy for  
cervical cancer consists of the induction of an effective anti-tumor  
response by available vaccines, combined with immune modulators that 
affect myeloid cell subsets. (this thesis)
3 As conventional, non-bone marrow sparing (chemo)radiotherapy 
profoundly suppresses the immune system in cervical cancer patients, 
studies on the immunological effects of bone marrow sparing radiotherapy 
should be made, especially when used in combination with immunotherapy 
(this thesis) 
4 Before standard conventional cancer treatments and immunotherapy can 
successfully be applied in cervical cancer, a considerable challenge relies 
in overcoming immunosuppression and optimizing delivery and dosing 
strategies of all therapies. (this thesis)
5 Within the identification of effective new immunotherapeutic strategies  
and combinations of treatments, the selection of patients in higher risk 
categories for recurrent cervical cancer is crucial to achieve that such 
treatments prevent recurrent disease. (this thesis)
6 Before new cancer treatments based on combinations of standard 
therapeutic modalities and immunotherapy are implemented into the clinic, 
detailed understanding of mode of (inter)action mechanisms is essential.
7 There are a few moments in a scientist’s live in which you have the 
impression to discover some light at the end of the tunnel, in which you 
scratch the surface of a problem and you see a solution: far away, uncertain 
but possible. (Guido Kroemer, Cancer: Defeating the Immortal. Cancer 
Biology & Therapy, 2007, 6:8, 1130-134)
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8 As an increasing number of compounds affecting the immune system is 
reaching the clinic, (future) clinical pharmacologists should expand their 
traditional pharmacology knowledge with fields such as immunonology 
and immuno-pharmacology to guard safety and well-being of subjects 
participating in clinical trials.
9 For a research physician, making successful combinations is an continuous 
challenge; combining conventional with new therapies, research and clinical 
work, and above all, work and private life. 
10 The highlights of tomorrow are the unpredictabilities of today (Cesar 
Milstein, Nobel Lecture for the Nobel Prize in Physiology or Medicine, 1984)
11 As 10% of conflicts is due to difference in opinion and the remaining 90%  
is due to wrong tone of voice (author unknown), one should every now  
and then remember the French phrase ‘C’est le ton qui fait la musique’.  
12 De meest bevlogen artsen zijn diegenen die, ondanks dat ze door de 
werkomstandigheden weinig thuis zijn, in staat zijn om met passie en 
enthousiasme het vak aan zijn of haar kinderen over te dragen opdat zij 
uiteindelijk voor hetzelfde beroep zullen kiezen. (geïnspireerd door mijn 
vader) 
13 It can take but a lifetime to paint like a child. (after Pablo Picasso, 1931)
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